An assessment of safety.

ASTRO white paper recommends particular guidance to follow in the delivery of HDR brachytherapy The American Culture for Radiation Oncology has issued a new white paper, An assessment of safety, quality management, and practice guidelines for high-dose-rate brachytherapy, that recommends specific guidance to follow in the delivery of high-dose-rate brachytherapy to improve quality and patient safety, according to the manuscript published in the March-April 2014 print problem of Practical Radiation Oncology , the state clinical practice journal of ASTRO. The executive summary and supplemental material are also obtainable as open-access articles on the web at Commissioned by ASTRO's Board of Directors within the Target Safely advertising campaign, the light paper evaluates the current safety and practice guidance for HDR brachytherapy, makes recommendations for assistance applications to the delivery of HDR brachytherapy, suggests topics where additional guidance is necessary and examines the adequacy of general physics, quality assurance and clinical guidance currently available for the most common treatment sites in regards to to patient safety. The manuscript also addresses HDR brachytherapy procedures, the usage of checklists and forms, the multidisciplinary treatment group, challenges to maintaining safe usage of HDR brachytherapy and crucial measures for avoiding catastrophic failing Generic Clomid .